March 25, 2026
eGenesis CEO Mike Curtis discusses how CRISPR-edited pig organs are becoming a clinical reality, serving as a vital bridge to human transplants.
March 11, 2026
CEO Markus Warmuth discusses how molecular glue degraders are unlocking
February 25, 2026
Alicia Zhou of CRI explains how nonprofits can act as the 'dark matter' of biotech, building foundational data infrastructure to unite and accelerate cancer immunotherapy.
February 11, 2026
IGI's Brad Ringeisen discusses translating CRISPR from lab theory to humanitarian solutions, applying a DARPA-inspired model to complex diseases.
January 7, 2026
Investor Bojang Wang discusses funding radical longevity tech like organ printing and mass gene therapy, challenging the core philosophy of medicine.
December 17, 2025
Host Jonathan Grinstein reviews his personal genomics tests & 2025's top precision medicine stories, from CRISPR advances to IVF controversies.